AR024823A1 - Uso de interferon alfa para el tratamiento de la familia de tumores de ewing - Google Patents
Uso de interferon alfa para el tratamiento de la familia de tumores de ewingInfo
- Publication number
- AR024823A1 AR024823A1 ARP010100188A ARP010100188A AR024823A1 AR 024823 A1 AR024823 A1 AR 024823A1 AR P010100188 A ARP010100188 A AR P010100188A AR P010100188 A ARP010100188 A AR P010100188A AR 024823 A1 AR024823 A1 AR 024823A1
- Authority
- AR
- Argentina
- Prior art keywords
- family
- interferon alfa
- treatment
- tumors
- ewing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se refiere al uso de interferon alfa para el tratamiento de la familia de tumores de Ewing en mamíferos. Se describe un método para la administracionde una cantidad terapéuticamente efectiva de interferon alfa a un mamífero afectado de un tumor de lafamilia de tumores de Ewing. La presente ademásse refiere a compuestos farmacéuticos adecuados conteniendo cantidades de interferon alfa terapéuticamente efectivas para su administracion a mamíferosen el tratamiento de tumores de la familia de tumores de Ewing.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00400132A EP1118330A1 (en) | 2000-01-19 | 2000-01-19 | Interferon-alpha use in the treatment of Ewing's family of tumors |
Publications (1)
Publication Number | Publication Date |
---|---|
AR024823A1 true AR024823A1 (es) | 2002-10-30 |
Family
ID=8173514
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010100188A AR024823A1 (es) | 2000-01-19 | 2001-01-17 | Uso de interferon alfa para el tratamiento de la familia de tumores de ewing |
Country Status (7)
Country | Link |
---|---|
EP (2) | EP1118330A1 (es) |
AR (1) | AR024823A1 (es) |
AT (1) | ATE265223T1 (es) |
AU (1) | AU2001223910A1 (es) |
DE (1) | DE60103016T2 (es) |
ES (1) | ES2220704T3 (es) |
WO (1) | WO2001052881A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10153584A1 (de) * | 2001-11-02 | 2003-05-15 | Megamedics Gmbh | Verfahren zur Indentifizierung Tumor-spezifischer Antigene auf Krebszellen |
RU2482871C2 (ru) * | 2010-06-07 | 2013-05-27 | Общество с ограниченной ответственностью "Центр Инновационных Технологий "БиоФарм" (ООО "ЦИТ "БиоФарм") | Композиция для лечения вирусных заболеваний животных |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999024060A1 (en) * | 1997-11-07 | 1999-05-20 | Mayo Foundation For Medical Education And Research | Interferon immunotherapy |
-
2000
- 2000-01-19 EP EP00400132A patent/EP1118330A1/en not_active Withdrawn
-
2001
- 2001-01-17 AR ARP010100188A patent/AR024823A1/es unknown
- 2001-01-18 AT AT01900214T patent/ATE265223T1/de not_active IP Right Cessation
- 2001-01-18 DE DE60103016T patent/DE60103016T2/de not_active Expired - Lifetime
- 2001-01-18 ES ES01900214T patent/ES2220704T3/es not_active Expired - Lifetime
- 2001-01-18 AU AU2001223910A patent/AU2001223910A1/en not_active Abandoned
- 2001-01-18 WO PCT/IB2001/000044 patent/WO2001052881A1/en active IP Right Grant
- 2001-01-18 EP EP01900214A patent/EP1250147B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ES2220704T3 (es) | 2004-12-16 |
DE60103016T2 (de) | 2005-04-07 |
AU2001223910A1 (en) | 2001-07-31 |
EP1250147A1 (en) | 2002-10-23 |
ATE265223T1 (de) | 2004-05-15 |
EP1250147B1 (en) | 2004-04-28 |
EP1118330A1 (en) | 2001-07-25 |
DE60103016D1 (de) | 2004-06-03 |
WO2001052881A1 (en) | 2001-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0207961A8 (pt) | Uso de análogos de epotilona e capecitabina para fabricar medicamento para tratar tumores cancerosos sólidos e kit compreendendo os referidos compostos. | |
AR072442A1 (es) | Metodo para la terapia del cancer, uso, kit | |
DE60030741D1 (de) | Chinazoline verbindungen als heilmittel | |
PA8542901A1 (es) | Uso de (z)-2-ciano-3-hidroxi-but-2-acido enoico-(4-trifluorometilfenil)-amida para tratar la esclerosis multiple | |
AR048336A1 (es) | Hidrocloruro de (4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il)-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos | |
BR0213424A (pt) | Uso aperfeiçoado de composto antitumoral na terapia contra câncer | |
GT200500191A (es) | Derivados de pirido - pirimidina, su preparacion, su aplicacion en terapeutica | |
BR0115162A (pt) | Tratamentos antitumorais eficazes | |
AR021912A1 (es) | Uso de apomorfina para el tratamiento de la disfuncion erectil organica en varones | |
ES2133324T3 (es) | Compuestos de dibenzoxazepina sustituidos, composiciones farmaceuticas y metodos de uso. | |
NO20025510D0 (no) | Tienodibenzoazulenforbindelser som tumor nekrose faktor inhibitorer | |
BR0213684A (pt) | Uso de antagonistas do receptor de endotelina para o tratamento de doenças tumorìgenas | |
BRPI0513943A (pt) | uso de um composto ou de um sal farmaceuticamente aceitável | |
AR021286A1 (es) | Un metodo de tratamiento de tumores en mamiferos mediante la administracion de compuestos que inducen la liberacion de la hormona del crecimiento y susantagonistas | |
IL159241A0 (en) | Use of branched-chain fatty acids and derivatives thereof for the treatment of pain | |
DE50212646D1 (de) | Verwendung von selenithältigen verbindungen zur topischen oder bukkalen anwendung | |
SE0004101D0 (sv) | New use | |
AR024823A1 (es) | Uso de interferon alfa para el tratamiento de la familia de tumores de ewing | |
CO5060499A1 (es) | Metodos y composiciones para el tratamiento de enfermedad de reflujo gastroesofagico | |
DE60113838D1 (de) | Derivate von triterpen-säuren | |
SE0100684D0 (sv) | New subject-matter | |
AR031126A1 (es) | Acidos amino(oxo)aceticos inhibidores de la proteina tirosina fosfatasa | |
SE0004827D0 (sv) | Therapeutic compounds | |
ES2134798T3 (es) | Uso de analogos de somatostatina para el tratamiento de melanomas. | |
AR007059A1 (es) | Uso de interferon en la preparacion de medicamentos y composiciones via oromucosal o por contacto |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |